8 Pharma Firms including Mylan, Aurobindo Pharma to pay Rs 18.25 lakh for allegedly violating green norms
Hyderabad: Violation of pollution control norms has costed eight pharmaceutical units each, including Hetero Labs, Aurobindo Pharma, and Mylan Laboratories that have been told to pay environmental compensation of Rs 18.25 lakh by the Telangana State Pollution Control Board (TSPCB).
The pharma firms in the soup are Hetero Labs, Shilpa Medicare, Aurobindo Pharma(two units), APL Health Care, Mylan Laboratory, Evertogen Life Sciences, Shri Kartikeya Pharma and Amneal Oncology.
As per a recent media report in The New Indian Express, TSPCB has further imposed a penalty on one pharma unit at the TSIIC SEZ in Polepally of Mahbubnagar district. However, TSPCB has allegedly acted in a biased manner as it considered only 365 days of violation whereas the original number of days is three times than that.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.